Correction: Baseline tumor size is an research independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab(Clin Cancer Res (2018)24(4960–7)DOI: 10.1158/1078-0432.CCR-17-2386)
暂无分享，去创建一个
J. Wolchok | A. Ribas | F. Hodi | P. Hersey | A. Patnaik | A. Daud | R. Kefford | C. Robert | R. Joseph | D. Alwis | O. Hamid | K. Anderson | J. Weber | S. Ebbinghaus | W. Hwu | Jin Zhang | A. Joshua | T. Gangadhar | R. Dronca | J. Elassaiss-Schaap | A. Perrone | S. Kang